Loading…
Loading…
1:15pm: An Apple-Intel deal in the works? Apple Inc (NASDAQ:AAPL, XETRA:APC) and Intel Corp (NASDAQ:INTC, XETRA:INL) have reportedly reached a preliminary...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares continued to extend recent gains on Monday as investors welcomed reports that the company is researching a...
FTSE 100 up 17 points to 10,251 Oil prices jump 5% after Iran counter-offer rejected by Pres Trump Bond market eyes speech from PM Starmer 11.31am:...
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) told investors that it has consented to Elevra Lithium transferring its rights and obligations in the...
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF) told investors that it has consented to Elevra Lithium transferring its rights and obligations in the Ewoyaa Lithium Project to Zhejiang Huayou Cobalt, potentially simplifying the funding route for Ghana's flagship lithium development. Elevra currently holds rights to a 22.5% interest in Atlantic's Ghana lithium portfolio, including Ewoyaa, after meeting the Stage 2 terms of the project agreement.
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF), the Africa-focused lithium explorer, has agreed to a takeover by Zhejiang Huayou Cobalt, a Chinese new...
Atlantic Lithium Ltd (AIM:ALL, ASX:A11, OTCID:ALLIF), the Africa-focused lithium explorer, has agreed to a takeover by Zhejiang Huayou Cobalt, a Chinese new energy materials company, in an all-cash deal valuing the company at approximately $210 million. Huayou will acquire all issued shares at a 26.6% premium to Atlantic's last closing price and 21.8% above its 30-day volume-weighted average price.
Shares in Shield Therapeutics PLC (AIM:STX, OTCQB:SHIEF) fell 12% to 7.71p after the group reported first-quarter revenue growth and positive earnings but...
No recent filings indexed.